
Longeveron Inc. (LGVN) Stock Price & Analysis
LGVNNASDAQHealthcareBiotechnology
As of Nov 20, 2026 close
- Market cap
- $5.84M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.48$8.90
- Volume (live)
- -
- Avg. volume (3M)
- 90.25K
Longeveron (LGVN) Stock Price Chart
Loading chart...
LGVN Key Statistics & Financial Metrics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.64 - $1.83 |
|---|---|
| 52-Week High | $8.90 |
| 52-Week Low | $0.48 |
| Open | $1.83 |
| Volume (last close) | 27.26K |
| Average Volume (3M) | 90.25K |
| Revenue (TTM) | 1.17M |
|---|---|
| Net Income (TTM) | −22.39M |
| Free Cash Flow (TTM) | −18.26M |
| EPS (TTM) | −$8.05 |
| Profit Margin | −1921.72% |
| Operating Margin | −2020.77% |
| Return on Equity (ROE) | −475.33% |
| Debt to Equity | 0.12 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 5.84M |
|---|---|
| Shares Outstanding | 3.21M |
| Price to Sales (P/S) | 5.02 |
| Price to Book (P/B) | 1.24 |
| EV/EBITDA | 0.04 |
| 50-Day MA | $2.44 |
|---|---|
| 200-Day MA | $3.60 |
| 1-Year Change | +203.33% |
Source: Market prices and company fundamentals. Data as of Nov 20, 2026. Data sources and methodology
Longeveron at a Glance
As of the Nov 20, 2026 close, Longeveron (LGVN) has a market capitalization of $5.84M. The stock trades at 5.0× sales. Over the trailing twelve months it lost $22.39M on revenue of $1.17M and burned $18.26M of free cash flow. Revenue fell 18.9% year over year.
As of its latest reported balance sheet, it holds $7.25M in cash and securities against $581.00K of debt, a net cash position of $6.66M.
Longeveron does not currently pay a dividend.
The share price is up 203.3% over the past year. At $1.66 (the Nov 20, 2026 close) it sits near the bottom of its 52-week range of $0.47 to $8.90, below its 200-day moving average of $3.60.
Frequently Asked Questions About Longeveron
What is the current stock price for LGVN?
As of the Nov 20, 2026 close, LGVN stock trades at $1.66. The 52-week range is $0.48–$8.90, with a day range of $1.64–$1.83.
What is the P/E ratio for LGVN?
Longeveron has no trailing P/E ratio because it reported a net loss over the last twelve months.
Does LGVN pay dividends?
Longeveron does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What is the market cap of LGVN?
As of the Nov 20, 2026 close, Longeveron's market capitalization is $5.3M, classifying it as a micro-cap company. Longeveron operates in the Healthcare sector within the Biotechnology industry.